INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 412m ago
HOUSE PTR12m ago
SEC 13F12m ago
ROBINHOOD CHAIN11m ago
Public company

FENCFENNEC PHARMACEUTICALS INC.

CIK 0001211583

EDGAR filingsOpen in network
Disclosed transactions44
Buys / sells0 / 1
Max Insider Score36
Connections6with evidence

FENC · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
156 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    Cook Jodi ADirector · Jun 10, 2026
  • ← Insider ofevidence
    Hackman Jeffrey S.Director, Chief Executive Officer · May 1, 2026
  • ← Insider ofevidence
    Evans Terry LChief Commercial Officer · Apr 2, 2026
5
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A
—
168 sh
Oct 31, 2026
Nov 2, 2026
traded Oct 31, 2026
+2d
SEC FORM 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
1,159 sh
Oct 31, 2026Nov 2, 2026
traded Oct 31, 2026
+2dSEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$12K
2,224 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

13
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$21K
3,846 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

13
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$22K
3,946 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

13
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$13K
2,326 sh
Oct 12, 2026Oct 13, 2026
traded Oct 12, 2026
+1dSEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
1,159 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

5
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
156 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC FORM 4

Evidence

36
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Open-market sale
SELL$146K
12.0K sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC FORM 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
156 sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
1,159 sh
Aug 31, 2026Aug 31, 2026
traded Aug 31, 2026
+0dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
1,159 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
156 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

16
CA
Cook Jodi ADirector
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$174K
20.0K sh
Jun 10, 2026Jun 10, 2026
traded Jun 10, 2026
+0dSEC FORM 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
May 31, 2026Jun 1, 2026
traded May 31, 2026
+1dSEC FORM 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
156 sh
May 31, 2026Jun 1, 2026
traded May 31, 2026
+1dSEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
1,159 sh
May 31, 2026Jun 1, 2026
traded May 31, 2026
+1dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
May 31, 2026Jun 1, 2026
traded May 31, 2026
+1dSEC FORM 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
1,159 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC FORM 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
168 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
168 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC FORM 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
155 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC FORM 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
18.5K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
18.5K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

21
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
17.1K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

19
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
2,052 sh
Mar 28, 2026Apr 2, 2026
traded Mar 28, 2026
+5dSEC FORM 4

Evidence

9
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
171 sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

27
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$692K
120.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

19
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
1,901 sh
Mar 28, 2026Apr 2, 2026
traded Mar 28, 2026
+5dSEC FORM 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
158 sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

27
SS
Sayad Pierre SargisChief Medical Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$692K
120.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

27
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A$692K
120.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

19
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
2,052 sh
Mar 28, 2026Apr 2, 2026
traded Mar 28, 2026
+5dSEC FORM 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
171 sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M$20K
4,700 sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC FORM 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M$20K
4,700 sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Sayad Pierre SargisChief Medical Officer · Apr 2, 2026
  • ← Insider ofevidence
    Cioffi Christiana MarieChief Strategy Officer · Mar 26, 2026